UK MHRA alerts companies to BSI standard on use of Braille
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare Products Regulatory Agency has issued an alert informing pharmaceutical companies about a BSI standard that provides guidance on the use of Braille on the packaging of medicinal products1,2. Companies demonstrating compliance to the standard (BS EN 15823:2010 Packaging: Braille on packaging for medicinal products), the agency says, will be regarded as meeting the regulatory provisions of the EU medicines legislation (Directive 2001/83/EC, as amended).
You may also be interested in...
Dutch Hospital Resumes Own Manufacture Of Leadiant’s Costly Drug
While the Dutch government negotiates an acceptable price for Leadiant Biosciences’ orphan drug CDCA, a university hospital has resumed supplying pharmacy compounded versions of the drug after addressing initial problems with the sourcing of raw materials.
Big Win For EMA On Transparency
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
EU Countries Test Offering Simultaneous Scientific Advice
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: